Medical Device "Silent Recalls" CDRH Is On the Lookout - Are You Prepared?
Product Details
If there’s a problem with a device, where do you draw the line between a routine servicing issue and a “risk to health” you must report to CDRH?
With the FDA cracking down on so-called silent recalls, making the wrong decision can lead straight to 483s, warning letters and even product seizures.
Nearly every devicemaker eventually encounters a serious product problem — and FDA inspectors are on the lookout for “silent recalls” as never before.
CDRH Director Jeffrey Shuren is responding to devicemakers’ concerns that a “corrective fix” pilot program forces them to recall older models when new versions are introduced — even when there are no consumer complaints submitted on the older device. Shuren hopes that information from a new regulatory science meeting in February 2010, along with findings from an internal task force formed to evaluate CDRH’s science practices, will lead to a recall practice policy.
Attend this 90-minute webinar with quality and compliance expert Michael Patrick Barile and you can stay proactive, making good decisions as device problems arise and preparing effectively for inspections.
Sign up your entire team for clear guidance on every aspect of 21 CFR Part 806 compliance, including:
- What events must be reported, who is the responsible party and what deadlines apply
- A step-by-step walkthrough of the FDA’s Health Hazard Evaluation form used to classify a recall
- Recordkeeping requirements that apply even if an event isn’t reportable
- 13 items that must be included with your removal or correction report
- 4 crucial steps to take before the inspection, including how to produce a single file containing all the information the inspector will want
- 6 keys to managing an inspection
- Dos and don’ts for clearing inspection hurdles (such as eliminating any “off- the-record” conversations)
- Real-world case study of how a company’s failure to properly report a device field correction resulted in a warning letter
- Where to send reports in the U.S., EU, Canada and Japan
Past attendees of this popular webinar weigh in favorably:
“This course provided a clearer view of how and when to communicate with FDA, giving me more confidence in how to handle the
reporting process.”
Richard Westrich, Vice-President, Regulatory Affairs and Quality Assurance, Ziehm Imaging, Inc.
“I thought this was easy to follow and it was a clear presentation.”
Christy Oviatt, Senior Regulatory Affairs Specialist, KCI USA, Inc.
Of course, Mr. Barile will be on hand to field your questions, too. Simply submit your questions via email, and you’ll have answers by the time the session ends.
And like every FDAnews webinar, Medical Device “Silent Recalls” is convenient to attend. All that’s required is that you be in front of a screen at the appointed time, whether you’re at the office or telecommuting from your office-in-home.
Better yet, one low registration fee per facility means you can sign up 10 — 20 — or more — of your colleagues and never pay a penny more. (Who should you sign up? See “Who Will Benefit,” below, for recommendations.)
The FDA is fed up with “silent recalls.” The agency considers every inspection to be an opportunity to search for evidence that they’ve occurred.
Protect your company and be prepared by attending Mr. Barile’s repeat performance of Medical Device “Silent Recalls” on Thursday, April 15.